A Randomized, Open Label Study to Compare the Current Phase II and Planned Phase III Capsule Formulation of AZD6244

Status:
Completed

Trial end date:
2012-10-01

Target enrollment:

Participant gender:

Study in Healthy Males to Compare the White and Blue Formulations of AZD6244.

Phase 1

AstraZeneca